Mark Chakravarty

Mark Chakravarty has a diverse and extensive work experience. Mark'smost recent role is as a Non-Executive Director at the Care Quality Commission, where they ensure that health and social care services in England provide safe, effective, compassionate, high-quality care.

Prior to this, they held the position of Vice Chairman and Non-Executive Director at the National Institute for Health and Care Excellence (NICE), where they played a key role in improving health and care services. Mark also served as a Non-Executive Director at Health Innovation Manchester, an organization dedicated to delivering health and care innovation in Greater Manchester.

Chakravarty has also contributed to the field of communication and technology as a Senior Advisor and Investor at Quantified, a company specializing in improving communication performance using behavioral science and AI. Mark was also a Board Advisor at Nye, a technology company.

Before venturing into the health and communication sectors, Chakravarty held various leadership roles at global companies such as Novartis and Procter & Gamble. Notably, they served as the SVP and Head of Communications & Patient Advocacy at Novartis Pharma, where they provided strategic advisory to the CEO and led cross-functional launch excellence initiatives.

At Procter & Gamble, Chakravarty held several positions, including Chief Communications Officer for Global Baby, Feminine & Family Care. Mark spearheaded the global communications function, overseeing PR, social brand building, media relations, and brand reputation management. Mark also played a key role in implementing the Social Brand Building framework for Pampers.

Chakravarty began their career at P&G Pharmaceuticals, where they held various roles, including Head of Government Affairs & NHS Policy. Mark led government affairs and health policy initiatives, particularly in the area of osteoporosis, achieving national and regional advocacy for a new drug.

Overall, Mark Chakravarty has a successful track record in various industries, including healthcare, communication, and technology, with a focus on improving patient care, innovation, and brand building.

Mark Chakravarty's education history includes the following:

- From 1989 to 1995, they attended The University of Manchester and earned a Doctor of Medicine (M.D.) degree in the field of Medicine.

- From 1997 to 1999, they attended Alliance Manchester Business School and obtained a Master of Business Administration (M.B.A.) degree.

- In 1989, they also completed a Bachelor's Degree in Pharmacology (Honours) at The University of Manchester, which they pursued until 1993.

- In 2017, they participated in an Executive Forum at Harvard Business School, focusing on Organizational Leadership.

- In 2020, they completed the Breakthrough Program for Senior Executives at IMD, specializing in Organizational Leadership.

- In 2021, they took part in a training program on Accountability & Governance for Arm's Length Bodies at the Civil Service College, concentrating on Audit & Risk.

- In 2022, they underwent Public Body Audit, Risk & Assurance Training at the UK Government Internal Audit Agency, with a focus on Audit & Risk.